WHC est encore en dévelopement. Lisez ceci pour comprendre notre approche.
depiction of NFLLKCVHYJRNRH-UHFFFAOYSA-N.svg
tripsit

dramamine

Vérifier sur tripsit

pubchem

Dimenhydrinate

Vérifier sur pubchem

drugmap

Dimenhydrinate

Vérifier sur drugmap

wiki

Dimenhydrinate

Vérifier sur wiki

Data

InChI: InChI=1S/C17H21NO.C7H7ClN4O2/c1-18(2)13-14-19-17(15-9-5-3-6-10-15)16-11-7-4-8-12-16;1-11-4-3(9-6(8)10-4)5(13)12(2)7(11)14/h3-12,17H,13-14H2,1-2H3;1-2H3,(H,9,10)

Synonymes: NSC-117855,Dimenidrinato [DCIT],DIMENHYDRINATE [HSDB],NCGC00257877-01,CHEBI:94848,Diphenhydramine Theoclate,Gravol,NCGC00021154-07,CCG-40210,Prestwick3_000265,2-benzhydryloxy-N,N-dimethylethanamine;8-chloro-1,3-dimethyl-7H-purine-2,6-dione,JB937PER5C,Diphenhydrinate,CHEMBL1200406,[o-Benzhydryl(dimethylamino)ethanol] 8-chlorotheophyllinate,CS-4841,NCGC00091928-03,HSDB 3064,SR-05000001608,DIMENHYDRINATE [VANDF],Dimenhydrinate (JP17/USP/INN),Theohydramine,HMS1920G20,Tox21_200323,Dramyl,Novamin (VAN),Emedyl,Dramamin,Q420439,NSC 117855,DIMENHYDRINATE [MI],DTXSID9025087,1H-Pyrine-2,6-dione, 8-chloro-3,7-dihydro-1,3-dimethyl-, compd. with 2-(diphenylmethoxy)-N,N-dimethylethanamine (1:1), Dimenhydrinate (JP15/USP/INN),Reidamine,NCGC00021154-06,Novamine,EN300-37158633,SR-05000001608-1,SPECTRUM1500251,Andramine,EINECS 208-350-8,gravol,Aviomarin,FT-0625019,Dramarin,D82297, Vertirosan (TN),Dimenhydrinate, Pharmaceutical Secondary Standard; Certified Reference Material,(o-Benzhydryl(dimethylamino)ethanol) 8-chlorotheophyllinate,Dramalen,N,N-Dimethyl-2-diphenylmethoxyethylamine 8-chlorotheophyllinate, Gravol (TN),DIMENHYDRINATE [ORANGE BOOK],Gravinol (antiemetic),Anautine,Spectrum2_000992,s4672,Spectrum3_000397,NCGC00021154-05,NCGC00091928-02,Ethylamine 2-(diphenylmethoxy)-N, compd. with 8-chlorotheophylline (1:1),1H-Purine-2,6-dione, 8-chloro-3,7-dihydro-1,3-dimethyl-, compd. with 2-(diphenylmethoxy)-N,N-dimethylethanamine (1:1),DIMENHYDRINATE [USP-RS],NSC-756740,KBioGR_001093,523D875,2-(diphenylmethoxy)-N,N-dimethylethanamine and 8-chloro-1,3-dimethyl-3,9-dihydro-1H-purine-2,6-dione,Chloranautine,MFCD00054265,HMS2095F12,Permital,KBio2_006590,2-(Diphenylmethoxy)-N,N-dimethylethylamine 8-chlorotheophyllinate,Dimenhydrinate, European Pharmacopoeia (EP) Reference Standard,Dimenidrinato,DIMENHYDRINATE [WHO-DD],DSSTox_GSID_25087,NCI-C60639,HMS3712F12,IDI1_000049,Gravamin (TN),Theophylline, 8-chloro-, compd with 2-(diphenylmethoxy)-N,N-dimethyethylamine (1:1),Dimenhydrinate for peak identification,AS-13166,D00520,Dimenest,Supremal,Benzhydryl-beta-dimethylaminoethylether 8-chlorotheophylline,Hydrinate,8-Chlorotheophylline, compound with 2-(diphenylmethoxy)-N,N-dimethylethylamine (1:1),KBio3_001433,HY-B1215,BRD-M98649031-001-01-1, 8-chloro-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione-2-(diphenylmethoxy)-N,N-dimethylethanamine (1:1),8-chloro-1,3-dimethyl-2,3,6,9-tetrahydro-1H-purine-2,6-dione; [2-(diphenylmethoxy)ethyl]dimethylamine,KBio2_001454,8-chloro-1,3-dimethyl-1H-purine-2,6(3H,7H)-dionecompoundwith2-(benzhydryloxy)-N,N-dimethylethanamine(1:1),Antemin,Spectrum5_000909,Theophylline, 8-chloro-, compd. with 2-(diphenylmethoxy)-N,N-dimethylethylamine (1:1),SCHEMBL5128,DSSTox_RID_77660,8-Chloro-1,3-dimethyl-1H-purine-2,6(3H,7H)-dione 2-(benzhydryloxy)-N,N-dimethylethanamine salt,dimenhydrinate,Ethylamine, 2-(diphenylmethoxy)-N, N-dimethyl-, compd. with 8-chlorothiophylline (1:1),NCGC00021154-01,KBio2_004022,DSSTox_CID_5087,Xamamina,Dimenhydrinate, United States Pharmacopeia (USP) Reference Standard,Amosyt,Teodramin,Troversin,O-Benzhydryldimethylaminoethanol 8-chlorotheophyllinate,DIMENHYDRINATE [INN],Eldodram,Ethylamine 2-(diphenylmethoxy)-N,N-dimethyl-, compd with 8-chlorotheophylline (1:1),Reise-Engletten,NSC756740,BD166163,KBioSS_001454,Dramilin,Diamarin,Dramamine (TN),DivK1c_000049,FT-0696921,Gravinol,Theophylline, compd. with 2-(diphenylmethoxy)-N,N-(dimethylethyl)amine (1:1), 8-chloro-1,3-dimethyl-2-oxopurin-6-olate,Dimenhydrinat,2-(Benzhydryloxy)-N,N-dimethylethylamine 8-chlorotheophyllinate,523-87-5,NCGC00021154-03,Dimenhydrinate for peak identification, European Pharmacopoeia (EP) Reference Standard,CCRIS 4798,Dimenhydrinatum [INN-Latin],Lomarin,Dommanate,Dimentabs,DIMENHYDRINATE [EP IMPURITY],SBI-0051350.P003,BSPBio_002213,SR-05000001608-2,DIMENHYDRINATE [MART.],Neo-Navigan,Faston,Dimenhydrinate,(S),Pharmakon1600-01500251,NINDS_000049,DIMENHYDRINATE [JAN],Ethylamine, N,N-dimethyl-2-(diphenylmethoxy)-, compd. with 8-chlorotheophylline,Dimenhydrinate [USP:INN:BAN:JAN],BPBio1_000122,Diphenhydramine 8-chlorotheophyllinate, 2-benzhydryloxyethyl(dimethyl)azanium, 2-(diphenylmethoxy)-N,N-dimethylethanaminium 8-chloro-1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydropurin-7-ide,Spectrum4_000517,Removine,NCGC00021154-04,Menhydrinate,Spectrum_000974,beta-Dimethylaminoethyl benzhydryl ether 1,3-dimethyl-8-chloroxanthine,SPBio_001083,HMS500C11,DIMENHYDRINATE [USP MONOGRAPH],8-Chlorotheophylline, compd. with 2-(diphenylmethoxy)-N,N-dimethylethylamine (1:1),Theophylline, compd. with 2-(diphenylmethoxy)-N,N-dimethylethylamine (1:1),8-chloro-1,3-dimethyl-1H-purine-2,6(3H,7H)-dione compound with 2-(benzhydryloxy)-N,N-dimethylethanamine (1:1),Dimenhidrinato [INN-Spanish],DB00985,1H-Purine-2, 8-chloro-3,7-dihydro-1,3-dimethyl-, compd. with 2-(diphenylmethoxy)-N,N-dimethylethanamine (1:1),DIMENHYDRINATE [EP MONOGRAPH],Dimate,NSC117855,NCGC00021154-02,AKOS015896341,Travelmin,NCGC00091928-01,HMS2091O08,Ethanamine, 2-(diphenylmethoxy)-N,N-dimethyl-, compd. with 8-chloro-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione (1:1),Vomex A,Diphenhydramine 8-chlorotheophylline,Travelin,WLN: T56 BM DN FNVNVJ CG F H &622,AB00053833,2-(Benzhydryloxy)-N,N-dimethylethylamine compd. with 8-chlorotheophylline,UNII-JB937PER5C,KBio1_000049,DIMENHYDRINATE,AC-8241,BSPBio_000110,Dromyl,Dramamine


Estimated data

Solubility: -4.829 (Salt Detected Prediction less reliable) (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 35.9% (prediction based on www.mdpi.com)

Similitudes

Voici une série de comparaisons visant à comprendre les propriétés de ce composé. Ce site est encore très expérimental et fait l'objet d'un développement actif. Veuillez vous référer à notre série d'articles d'articles pour bien comprendre notre approche et ses limites. Ces informations sont données à titre indicatif et ne doivent pas être interprétées comme des conseils médicaux.